IOVA
Iovance Biotherapeutics Inc
13.30$
+3.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -17,928.1% | -17,421.2% | -17,102.0% | -316.4% | -100.7% | -99.5% | -210.2% | -112.5% | -116.7% | -60.6% | -100.9% | -61.3% | -81.3% | |
| 2,105.5% | 2,015.4% | 1,385.6% | 34.9% | 19.0% | 15.9% | 22.4% | 19.9% | 17.1% | 14.6% | 14.6% | 10.5% | 13.8% | |
| 3,373.3% | 2,987.3% | 2,402.5% | 97.9% | 53.0% | 42.0% | 46.5% | 24.9% | 17.6% | 13.6% | 15.8% | 11.8% | 14.4% | |
| 1,255.9% | 2,466.4% | -4,552.3% | -124.4% | -22.7% | -51.5% | -35.7% | 15.3% | -12.6% | -8.4% | -18.0% | -36.1% | -19.9% | |
| 762.7% | 732.2% | 583.4% | 1.4% | 3.9% | 5.7% | 12.6% | 12.4% | 16.1% | 10.7% | 9.3% | 5.5% | 9.9% | |
| -16,847.3% | -15,113.1% | -15,595.2% | 129.3% | -83.3% | 32.1% | 32.2% | 23.1% | 25.2% | 0.9% | 16.0% | -74.6% | -13.8% | |
| -80.8% | -38.6% | -657.5% | -3.2% | 12.4% | – | – | – | 1.0% | 0.2% | – | 0.9% | – | |
| 43,240.9% | 199.6% | 27,073.6% | 491.3% | 71.7% | 3.1% | 290.6% | 22.1% | 130.5% | 64.7% | 132.1% | 49.6% | 88.6% | |
| 8,040.5% | -31,707.9% | -5,692.3% | 303.8% | -110.3% | -65.8% | 113.5% | -66.1% | 38.1% | 5.7% | -219.9% | -191.8% | -97.5% | |
| -18,690.8% | -18,153.3% | -17,685.3% | -317.9% | -104.6% | -105.1% | -222.8% | -124.9% | -132.7% | -71.3% | -110.2% | -66.7% | -91.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.